SCHEMBL14595080

SCHEMBL14595080

Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCc5ccccc5C4)cc32)c(C)c1C(=O)NCCCN1CCN(C)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 3/20 0.60
▸ KDR P35968 9/20 0.56
▸ PDGFRB P09619 8/20 0.56
▸ FGFR1 P11362 7/20 0.56
▸ TLK2 Q86UE8 2/20 0.56
▸ PRKAA2 P54646 5/20 0.50
▸ PRKAA1 Q13131 5/20 0.50
▸ LRRK2 Q5S007 1/20 0.50
▸ HDAC3 O15379 2/20 0.49
▸ HDAC4 P56524 2/20 0.49
▸ HDAC1 Q13547 2/20 0.49
▸ HDAC7 Q8WUI4 2/20 0.49
▸ HDAC2 Q92769 2/20 0.49
▸ HDAC10 Q969S8 2/20 0.49
▸ HDAC11 Q96DB2 2/20 0.49
▸ HDAC8 Q9BY41 2/20 0.49
▸ HDAC6 Q9UBN7 2/20 0.49
▸ HDAC9 Q9UKV0 2/20 0.49
▸ HDAC5 Q9UQL6 2/20 0.49
▸ MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14595088 0.89 MET (0.75) METKDRPDGFRBFGFR1TLK2
SCHEMBL14595082 0.87 MET (0.69) METKDRPDGFRBFGFR1TLK2
SCHEMBL5412076 0.86 MET (0.79) METKDRPDGFRBFGFR1TLK2
SCHEMBL14595081 0.84 MET (0.63) METKDRPDGFRBFGFR1TLK2
SCHEMBL5412102 0.83 MET (0.54) METKDRPDGFRBFGFR1
SCHEMBL2114525 0.83 PDGFRB (0.69) METKDRPDGFRBFGFR1TLK2
SCHEMBL14595085 0.82 MET (0.73) METKDRPDGFRBFGFR1TLK2
SCHEMBL31672543 0.81 PDGFRB (0.83) METKDRPDGFRBFGFR1TLK2
SCHEMBL31672462 0.81 KDR (0.69) KDRPDGFRBFGFR1TLK2PRKAA2
SCHEMBL31672526 0.81 PDGFRB (0.69) KDRPDGFRBFGFR1TLK2PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7157577-B2 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors SUGEN INC. (US) 2007-01-02 — — US disclosed
US-7157577-B2 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors SUGEN INC. (US) 2007-01-02 — — US disclosed
Send feedback